Prof. Dr.
Fatih Aydoğan
Verified specialist profile with transparent experience and patient feedback.
-
Medical Unit: Oncological Surgery Center
-
Turkey, Istanbul
-
24+ Years Experience
- 0.0 (0 reviews)
Prof. Dr. Fatih Aydoğan is a general surgeon and surgical oncologist at Acıbadem Altunizade and Ataşehir hospitals in Istanbul, focusing on oncoplastic surgery, breast cancer management and the follow-up of high-risk patients. He trained at Istanbul University, holds the European Board of Breast Surgery certificate, and was a research fellow at Dana-Farber and Brigham and Women's Hospital. He previously served as founding director of the Memorial Bahçelievler Breast Health Center.
Professional Profile
+About
Prof. Dr. Fatih Aydoğan is a general surgeon and surgical oncologist at Acıbadem Altunizade and Ataşehir hospitals in Istanbul, focusing on oncoplastic surgery, breast cancer management and the follow-up of high-risk patients. He trained at Istanbul University, holds the European Board of Breast Surgery certificate, and was a research fellow at Dana-Farber and Brigham and Women's Hospital. He previously served as founding director of the Memorial Bahçelievler Breast Health Center.
+Education
- 1999 - Istanbul University Istanbul Faculty of Medicine (MD)
- 2005 - Istanbul University Cerrahpaşa Faculty of Medicine - General Surgery specialization
- 2012 - Surgical Oncology subspecialty
- 2012 - European Board of Breast Surgery certificate, Valencia, Spain
- 2014 - Brigham and Women's Hospital - Research Fellowship on Breast Surgery
- 2015 - Harvard / Dana-Farber Cancer Institute - Research Fellowship on Breast Cancer
+Experience
- Since 2025 - Acıbadem Healthcare Group
- 2025 - Yale School of Medicine, Department of Surgery - Visiting International Scholar
- 2025 - Asan Medical Center Breast Center, South Korea - Visiting International Scholar
- 2019-2025 - American Society of Breast Surgeons, Question of the Week Program - Committee Member
- 2018-2025 - Memorial Bahçelievler Hospital, Breast Health Center - Founding Director
- 2005-2017 - Cerrahpaşa Faculty of Medicine, Breast Diseases Service - Specialist / Faculty Member
- 2011 - MD Anderson Cancer Center, Genetics and High-Risk Patients Department - Observer
- 2005 - National Cancer Institute, Breast Center, Tokyo - Observer
- 2004 - European Institute of Oncology, Senology - Visiting Surgeon
- 2003 - Memorial Sloan Kettering Cancer Center, New York, Surgical Oncology - Observer
- 2003 - Mount Sinai Hospital - Transplantation, Breast Surgery
- 2003 - Cornell University Presbyterian Hospital, New York, Breast Surgery - Observer
- 2002 - Massachusetts General Hospital - Breast Surgery, Thoracic Surgery
+Memberships
- American Society of Clinical Oncology
- Senology Society (Turkey)
- American Society of Breast Surgeons
- Istanbul Chamber of Physicians
- Oncoplastic Breast Consortium
+International Papers
Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg. 2017;265:581-589. Sagara Y, Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT,...
- Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. Ann Surg. 2017;265:581-589.
- Sagara Y, Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT, Golshan M. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study. JAMA Surg. 2015;150:739-45.
- Sagara Y, Freedman RA, Vaz-Luis I, Mallory MA, Wong SM, Aydogan F, DeSantis S, Barry WT, Golshan M. Patient Prognostic Score and Associations with Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study. J Clin Oncol. 2016;34:1190-6.
- Sanli AN, Turan B, Tekcan Sanli DE, Karaca I, Altundag MK, Aydogan F. Neoadjuvant response stratification based on complete, partial, and no response in HR-positive/HER2-positive breast cancer. Breast Cancer Res Treat. 2025;214:247-264.
- Sanli AN, Turan B, Tekcan Sanli DE, Aydogan F, Altundag MK. Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study. Breast Cancer. 2025;32:1061-1074.
- Eyuboglu AA, Akdemir O, Aydogan F, Isken MT. Implant-Based Breast Reconstruction with Bovine Pericardium: Our Approach Using Tutopatch and Review of Literature. Aesthetic Plast Surg. 2024;48:285-296.
- Aydogan T, Sezgin E, Ilvan S, Yilmaz OC, Aslan N, Golshan M, Aydogan F. Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study. Clin Breast Cancer. 2020;20(1):e9-e13.
- Aydogan F, Velidedeoglu M, Kilic F, Yilmaz H. Radio-guided localization of clinically occult breast lesions: current modalities and future directions. Expert Rev Med Devices. 2014;11:53-63.
Facility Amenities & Services
Premises
Patient reviews
We value your trust above all, so clinics can't pay to alter or remove reviews.
Learn more about reviews.